Kurt F. Somerville’s AbbVie ABBV Stock Holding History

Kurt F. Somerville’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Sell	5,261 -340	-6%	-$73.2K	0.32%	44
2026 Q1	$1.22M	Sell	5,601 -706	-11%	-$157K	0.32%	47
2025 Q4	$1.44M	Sell	6,307 -850	-12%	-$194K	0.24%	48
2025 Q3	$1.66M	Sell	7,157 -150	-2%	-$30.5K	0.27%	46
2025 Q2	$1.36M	Sell	7,307 -25	-0.3%	-$4.65K	0.23%	50
2025 Q1	$1.54M	Hold	7,332	–	–	0.27%	47
2024 Q4	$1.3M	Sell	7,332 -30	-0.4%	-$5.52K	0.22%	48
2024 Q3	$1.45M	Sell	7,362 -90	-1%	-$16.8K	0.23%	51
2024 Q2	$1.28M	Sell	7,452 -25	-0.3%	-$4.14K	0.22%	53
2024 Q1	$1.36M	Hold	7,477	–	–	0.23%	51
2023 Q4	$1.16M	Sell	7,477 -101	-1%	-$14.7K	0.22%	50
2023 Q3	$1.13M	Sell	7,578 -248	-3%	-$36.4K	0.23%	52
2023 Q2	$1.05M	Sell	7,826 -8,496	-52%	-$1.25M	0.2%	53
2023 Q1	$2.6M	Sell	16,322 -240	-1%	-$36.7K	0.47%	40
2022 Q4	$2.68M	Hold	16,562	–	–	0.52%	37
2022 Q3	$2.22M	Sell	16,562 -290	-2%	-$41.6K	0.45%	43
2022 Q2	$2.58M	Sell	16,852 -1,366	-7%	-$209K	0.49%	42
2022 Q1	$2.95M	Sell	18,218 -1,588	-8%	-$231K	0.48%	42
2021 Q4	$2.68M	Sell	19,806 -60	-0.3%	-$7.09K	0.37%	42
2021 Q3	$2.14M	Sell	19,866 -200	-1%	-$22.9K	0.33%	41
2021 Q2	$2.26M	Sell	20,066 -715	-3%	-$80.5K	0.34%	43
2021 Q1	$2.25M	Buy	20,781 +466	+2%	+$49.8K	0.36%	44
2020 Q4	$2.18M	Hold	20,315	–	–	0.35%	45
2020 Q3	$1.78M	Sell	20,315 -2,060	-9%	-$194K	0.31%	45
2020 Q2	$2.2M	Buy	22,375 +1,800	+9%	+$158K	0.41%	42
2020 Q1	$1.57M	Sell	20,575 -850	-4%	-$72.4K	0.35%	46
2019 Q4	$1.9M	Sell	21,425 -1,735	-7%	-$144K	0.36%	42
2019 Q3	$1.75M	Hold	23,160	–	–	0.35%	42
2019 Q2	$1.68M	Sell	23,160 -1,000	-4%	-$78.6K	0.33%	42
2019 Q1	$1.95M	Sell	24,160 -1,000	-4%	-$81.8K	0.39%	39
2018 Q4	$2.32M	Sell	25,160 -100	-0.4%	-$8.79K	0.53%	38
2018 Q3	$2.39M	Sell	25,260 -75	-0.3%	-$7.11K	0.48%	40
2018 Q2	$2.35M	Sell	25,335 -1,500	-6%	-$146K	0.52%	38
2018 Q1	$2.54M	Sell	26,835 -1,218	-4%	-$134K	0.56%	37
2017 Q4	$2.71M	Sell	28,053 -1,097	-4%	-$103K	0.56%	38
2017 Q3	$2.59M	Sell	29,150 -1,200	-4%	-$91.3K	0.52%	39
2017 Q2	$2.2M	Sell	30,350 -1,290	-4%	-$86.7K	0.45%	43
2017 Q1	$2.06M	Sell	31,640 -200	-0.6%	-$12.6K	0.44%	45
2016 Q4	$1.99M	Sell	31,840 -100	-0.3%	-$6.1K	0.44%	45
2016 Q3	$2.01M	Sell	31,940 -100	-0.3%	-$6.47K	0.44%	48
2016 Q2	$1.98M	Hold	32,040	–	–	0.45%	50
2016 Q1	$1.83M	Sell	32,040 -4,385	-12%	-$244K	0.42%	51
2015 Q4	$2.16M	Buy	36,425 +3,875	+12%	+$223K	0.49%	48
2015 Q3	$1.77M	Buy	32,550 +550	+2%	+$35.8K	0.45%	46
2015 Q2	$2.15M	Hold	32,000	–	–	0.5%	46
2015 Q1	$1.87M	Buy	32,000 +5,400	+20%	+$326K	0.43%	46
2014 Q4	$1.74M	Buy	26,600 +960	+4%	+$60.5K	0.43%	47
2014 Q3	$1.48M	Sell	25,640 -700	-3%	-$38.9K	0.6%	44
2014 Q2	$1.49M	Hold	26,340	–	–	0.58%	44
2014 Q1	$1.35M	Sell	26,340 -300	-1%	-$15.2K	0.54%	46
2013 Q4	$1.41M	Sell	26,640 -50	-0.2%	-$2.46K	0.54%	43
2013 Q3	$1.19M	Hold	26,690	–	–	0.48%	48
2013 Q2	$1.1M	Buy	+26,690	New	+$1.17M	0.46%	50

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kurt F. Somerville's ABBV Position: Q2 2026 in Review

Kurt F. Somerville reduced its AbbVie (ABBV) stake by 6.1% in Q2 2026, selling an estimated $73.2K and leaving 5,261 shares worth $1.32M. The position accounts for 0.32% of the portfolio, ranked #44.

Kurt F. Somerville first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.95M in Q1 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Kurt F. Somerville held 5,261 shares of AbbVie worth $1.32M as of Q2 2026.
Kurt F. Somerville sold 340 AbbVie shares in Q2 2026, an estimated $73.2K.
AbbVie made up 0.32% of Kurt F. Somerville's portfolio in Q2 2026, its #44 holding.
Kurt F. Somerville first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Kurt F. Somerville's AbbVie position peaked at $2.95M in Q1 2022.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kurt F. Somerville's 13F filing for Q2 2026, filed 11 Aug 2026.